메뉴 건너뛰기




Volumn 47, Issue 2, 2008, Pages 266-267

The Achilles' heel of HIV treatment in resource-limited settings [7]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR;

EID: 38649137701     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31815b2142     Document Type: Letter
Times cited : (3)

References (8)
  • 1
    • 34347338692 scopus 로고    scopus 로고
    • Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Cote d'Ivoire
    • Eholie SP, Tanon A, Polneau S, et al. Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr. 2007;45:355-358.
    • (2007) J Acquir Immune Defic Syndr , vol.45 , pp. 355-358
    • Eholie, S.P.1    Tanon, A.2    Polneau, S.3
  • 2
    • 0036405207 scopus 로고    scopus 로고
    • Is average adherence to HIV antiretroviral therapy enough?
    • Bangsberg DR, Deeks SG. Is average adherence to HIV antiretroviral therapy enough? J Gen Intern Med. 2002;17:812-813.
    • (2002) J Gen Intern Med , vol.17 , pp. 812-813
    • Bangsberg, D.R.1    Deeks, S.G.2
  • 3
    • 33645601918 scopus 로고    scopus 로고
    • Anti-retroviral adherence in a resource poor setting [abstract]
    • Presented at:, Bangkok
    • Akam A. Anti-retroviral adherence in a resource poor setting [abstract]. Presented at: International AIDS Conference; 2004; Bangkok.
    • (2004) International AIDS Conference
    • Akam, A.1
  • 4
    • 34248577886 scopus 로고    scopus 로고
    • Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa
    • Hardon AP, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19:658-665.
    • (2007) AIDS Care , vol.19 , pp. 658-665
    • Hardon, A.P.1    Akurut, D.2    Comoro, C.3
  • 5
    • 13244263044 scopus 로고    scopus 로고
    • Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy
    • Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, et al. Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. Int J STD AIDS. 2005;16:38-41.
    • (2005) Int J STD AIDS , vol.16 , pp. 38-41
    • Byakika-Tusiime, J.1    Oyugi, J.H.2    Tumwikirize, W.A.3
  • 6
    • 0242496506 scopus 로고    scopus 로고
    • Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana
    • Weiser S, Wolfe W, Bangsberg D, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34:281-288.
    • (2003) J Acquir Immune Defic Syndr , vol.34 , pp. 281-288
    • Weiser, S.1    Wolfe, W.2    Bangsberg, D.3
  • 7
    • 34247571878 scopus 로고    scopus 로고
    • Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda
    • Oyugi JH, Byakika-Tusiime J, Ragland K, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS. 2007;21:965-971.
    • (2007) AIDS , vol.21 , pp. 965-971
    • Oyugi, J.H.1    Byakika-Tusiime, J.2    Ragland, K.3
  • 8
    • 2342589337 scopus 로고    scopus 로고
    • Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy
    • Parienti J, Massari V, Descamps D, et al. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clin Infect Dis. 2004;38:1311-1316.
    • (2004) Clin Infect Dis , vol.38 , pp. 1311-1316
    • Parienti, J.1    Massari, V.2    Descamps, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.